Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #9553 on Manhattan Scientifics Inc (MHTX)
ssc
12/08/23 8:47 AM
#9554 RE: rustydog62 #9553
The Company continues to work towards its Investigational New Drug application for submission to the US FDA, which was initially planned for Q1:2024, but now likely to be delayed as Imagion works to ensure sufficient resources are in place to pursue clinical development of the MagSense imaging technology.